Matched tumor and adjacent normal mucosa from 24 CRC patients revealed approximately 5-fold higher ITLN1 mRNA in the malignant tissue, accompanied by markedly increased protein levels as shown by immunohistochemistry. This evidence concerns the gene ITLN1 and colorectal carcinoma.